Milestone Pharmaceuticals Inc. (MIST) Misses Q1 EPS by 43c

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q1 EPS of ($0.20), $0.43 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $238 thousand versus the consensus estimate of $56.34 million.

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.

You May Also Be Interested In

• Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
• Akeso's ivonescimab beats durvalumab in biliary tract cancer trial
• Zoom (ZM) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance